Short- and medium-term clinical efficacy of three endoscopic therapies for achalasia: A single-blinded prospective study

Revista Espanola de Enfermedades Digestivas

Volumn 95, Issue 1, 2003, Pages 22-29

  Caunedo, Angel ^a   Romero, R ^a   Hergueta, P ^a   Gomez B J ^a   Rodriguez Tellez M ^a   Linares, E ^a   Sanchez Gey S ^a   Pellicer, F J ^a   Herrerias J M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Achalasia; Botulinum toxin; Combined therapy; Endoscopic sclerotherapy; Predictive factor of response

Indexed keywords

BOTULINUM TOXIN; POLIDOCANOL; MACROGOL DERIVATIVE; SCLEROSING AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; DYSPHAGIA; ENDOSCOPIC THERAPY; ESOPHAGUS ACHALASIA; ESOPHAGUS MANOMETRY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; INJECTION SITE; INTERMETHOD COMPARISON; LOWER ESOPHAGUS SPHINCTER; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SYMPTOMATOLOGY; THORAX PAIN; TREATMENT OUTCOME; COMPARATIVE STUDY; DRUG COMBINATION; ENDOSCOPY; FOLLOW UP; INJECTION; MIDDLE AGED; SCLEROTHERAPY; TIME;

ADULT; BOTULINUM TOXINS; DRUG THERAPY, COMBINATION; ENDOSCOPY; ESOPHAGEAL ACHALASIA; ESOPHAGOGASTRIC JUNCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; SCLEROSING SOLUTIONS; SCLEROTHERAPY; TIME FACTORS;

EID: 0037219010     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Reynolds JC, Parkman HP. Achalasia. Gastroenterol Clin North Am 1989; 18: 223-55.
2. Ponce J, Garrigues V, Pertejo V, Sala T, Berenguer J. Individual prediction of response to pneumatic dilation in patients with achalasia. Dig Dis Sci 1996; 41: 2135-41.
3. Katz PO, Gilbert J, Castell DO. Pneumatic dilation is effective long term treatment for achalasia. Dig Dis Sci 1998; 43: 1973-7.
4. Vaezi MF, Richter JE. Current Therapies for achalasia: comparision and efficacy. J Clin Gastroenterol 1998; 27: 21-35.
5. Rosati R, Fumagalli U, Bona S, Bonavina L, Pagani M, Perachia A. Evaluating results of laparoscopic surgery for esophageal achalasia. Surg Endos 1998; 12: 270-3.
6. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre SS, Jones B, Kalloo AN. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995; 332: 774-8.
7. Pasricha, PJ, Rai R, Ravich WJ, Hendrix TR, Kalloo AN. Botulinum toxin for achalasia: Long-term outcome and predictors of response. Gastroenterology 1996; 110: 1410-5.
8. Fishman VM, Parkman HP, Schiano TD, et al. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol 1996; 91: 1724-30.
9. Annese V, Basciani M. Perri F, et al. Controlled trial of botulinum, toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology 1996; 111: 1418-24.
10. Culliere C, Ducrotte P, Zerbib F, et al. Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut 1997; 41: 87-92.
11. Prakash C, Freedland KE, Chan MF, Clouse RE. Botulinum toxin injection for achalasia symptoms can approximate the short term efficacy of a single pneumatic dilation: a survival analysis approach. Am J Gastroenterol 1999; 94: 328-33.
12. Vaezi MF, Richter JE, Wilcox CM, Schroeder PL, Birgisson S. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut 1999; 44: 231-9.
13. Gordon JM, Eaker EY. Prospective study of esophageal botulinum toxin injection in high-risk achalasia patients. Am J Gastroenterol 1997; 10: 1812-7.
14. Wehrman T, Kokabpick H, Jacobi V, Seifert H, Lembcke B, Caspary WF. Long-term results of endoscopic injection of botulinum toxin in elderly achalasic patients with tortuous megaesophagus or epiphrenic diverticulum. Endoscopy 1999; 31: 352-8.
15. Moretó M, Ojembarrena E, Rodriguez ML. Endoscopic injection of ethanolamine as a treatment for achalasia: a first report. Endoscopy 1996; 28: 539-45.
16. Moretó M, Barturen A, Ojembarrena. E, Casado L. Treatment of achalasia by injection of sclerosants: a long term experience. Gastrointest Endosc 1999; 49: AB128.
17. Velloso A, Bozada JM, Pizarro A, García E. Tratamiento de la achalasia mediante inyección de toxina botulínica (TB) en cardias. Resultados a largo plazo. Rev Esp Enferm Digest 1997; 89 (Supl. I): A45.
18. Espinel J, Olcoz JL, Jorquera F, Gundín MJ, Muñoz F, Tascón R. Tratamiento de la achalasia idiopática mediante toxina botulínica. Rev Esp Enferm Digest 1997; 89 (Supl. I): A101.
19. Eaker EY, Gordon JM, Vogel SB. Untoward effects of esophageal botulinum toxin injection in the treatment of achalasia. Dig Dis Sci 1997; 42: 724-7.
20. Branton SA, DeVault KR, Achem SR, et al. Prior botulinum toxin injection does not affect laparoscopic myotomy for achalasia. Am J Gastroenterol 1998; 93: 1611.
21. Panaccione R, Gregor JC, Reynolds RPE. A cost minimization analysis of intrasphincteric botulinum toxin versus pneumatic dilatation in patients with achalasia. Gastroenterology 1997; 112: A250.
22. Imperiale TF, O'Connor JB, Vaezi MF, et al. A cost-analysis of alternative treatment strategies for achalasia. Gastroenterology 1998; 114: A19.
23. Panaccione R, Gregor JC, Reynolds RPE, Preiksaitis HG. Intrasphincteric botulinum toxin versus pneumatic dilatation for achalasia: a cost minimization analysis. Gastrointest Endosc 1999; 50: 492-8.